CA1139222A - Compose galenique - Google Patents
Compose galeniqueInfo
- Publication number
- CA1139222A CA1139222A CA000342212A CA342212A CA1139222A CA 1139222 A CA1139222 A CA 1139222A CA 000342212 A CA000342212 A CA 000342212A CA 342212 A CA342212 A CA 342212A CA 1139222 A CA1139222 A CA 1139222A
- Authority
- CA
- Canada
- Prior art keywords
- composition according
- enteric
- coating
- sterol
- ergot alkaloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH13021/78 | 1978-12-21 | ||
CH13019/78 | 1978-12-21 | ||
CH1302178 | 1978-12-21 | ||
CH1301978 | 1978-12-21 | ||
CH56679 | 1979-01-19 | ||
CH567/79 | 1979-01-19 | ||
CH566/79 | 1979-01-19 | ||
CH56779 | 1979-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1139222A true CA1139222A (fr) | 1983-01-11 |
Family
ID=27427929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000342212A Expired CA1139222A (fr) | 1978-12-21 | 1979-12-19 | Compose galenique |
Country Status (23)
Country | Link |
---|---|
AT (1) | AT372279B (fr) |
AU (1) | AU534051B2 (fr) |
CA (1) | CA1139222A (fr) |
CH (1) | CH642259A5 (fr) |
CY (1) | CY1330A (fr) |
DE (1) | DE2950154A1 (fr) |
DK (1) | DK154607C (fr) |
FI (1) | FI793888A (fr) |
FR (1) | FR2444463A1 (fr) |
GB (1) | GB2038181B (fr) |
HK (1) | HK37986A (fr) |
HU (1) | HU182577B (fr) |
IE (1) | IE49323B1 (fr) |
IL (1) | IL59003A (fr) |
IT (1) | IT1164029B (fr) |
KE (1) | KE3617D (fr) |
MY (1) | MY8500129A (fr) |
NL (1) | NL187229C (fr) |
NZ (1) | NZ192457A (fr) |
PH (1) | PH25178A (fr) |
PT (1) | PT70614A (fr) |
SE (1) | SE442265B (fr) |
WO (1) | WO1980001242A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE14379T1 (de) * | 1981-04-27 | 1985-08-15 | Haessle Ab | Pharmazeutisches praeparat. |
US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
HU192050B (en) * | 1983-04-22 | 1987-05-28 | Sandoz Ag | Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist |
DE3413955A1 (de) * | 1983-04-22 | 1984-10-25 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten |
HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
GB8426922D0 (en) * | 1984-10-24 | 1984-11-28 | Sandoz Ltd | Galenic formulation |
AT388101B (de) * | 1985-02-05 | 1989-05-10 | Sandoz Ag | Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung |
CN1003978B (zh) * | 1987-09-05 | 1989-04-26 | 广州陈李济药厂 | 一种补脾益肠丸的制备工艺 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3432593A (en) * | 1963-09-18 | 1969-03-11 | Key Pharm Inc | Delayed and sustained release type pharmaceutical preparation |
DE2528257C2 (de) * | 1974-07-04 | 1986-02-13 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue galenische Zubereitung |
DE2546577B2 (de) * | 1975-10-17 | 1981-04-02 | Sandoz-Patent-GmbH, 7850 Lörrach | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
-
1979
- 1979-12-12 WO PCT/CH1979/000160 patent/WO1980001242A1/fr unknown
- 1979-12-12 DK DK529879A patent/DK154607C/da not_active IP Right Cessation
- 1979-12-12 SE SE7910227A patent/SE442265B/sv not_active IP Right Cessation
- 1979-12-12 FI FI793888A patent/FI793888A/fi not_active Application Discontinuation
- 1979-12-12 CH CH626380A patent/CH642259A5/de not_active IP Right Cessation
- 1979-12-13 DE DE19792950154 patent/DE2950154A1/de active Granted
- 1979-12-18 NL NLAANVRAGE7909105,A patent/NL187229C/xx not_active IP Right Cessation
- 1979-12-19 CA CA000342212A patent/CA1139222A/fr not_active Expired
- 1979-12-19 GB GB7943633A patent/GB2038181B/en not_active Expired
- 1979-12-19 IL IL59003A patent/IL59003A/xx unknown
- 1979-12-19 IE IE2471/79A patent/IE49323B1/en unknown
- 1979-12-19 PT PT70614A patent/PT70614A/fr not_active IP Right Cessation
- 1979-12-19 PH PH23436A patent/PH25178A/en unknown
- 1979-12-19 AU AU54031/79A patent/AU534051B2/en not_active Ceased
- 1979-12-19 CY CY1330A patent/CY1330A/xx unknown
- 1979-12-19 NZ NZ192457A patent/NZ192457A/xx unknown
- 1979-12-20 HU HU79SA3216A patent/HU182577B/hu not_active IP Right Cessation
- 1979-12-20 IT IT51153/79A patent/IT1164029B/it active
- 1979-12-20 AT AT0803679A patent/AT372279B/de active
- 1979-12-20 FR FR7931229A patent/FR2444463A1/fr active Granted
-
1985
- 1985-12-30 MY MY129/85A patent/MY8500129A/xx unknown
-
1986
- 1986-03-18 KE KE3617BD patent/KE3617D/xx unknown
- 1986-05-22 HK HK379/86A patent/HK37986A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB2038181A (en) | 1980-07-23 |
HU182577B (en) | 1984-02-28 |
AU5403179A (en) | 1980-06-26 |
AU534051B2 (en) | 1984-01-05 |
DK154607B (da) | 1988-12-05 |
ATA803679A (de) | 1983-02-15 |
HK37986A (en) | 1986-05-30 |
IE792471L (en) | 1980-06-21 |
FI793888A (fi) | 1980-06-22 |
DK154607C (da) | 1989-06-05 |
DE2950154C2 (fr) | 1989-05-11 |
PH25178A (en) | 1991-03-27 |
NL7909105A (nl) | 1980-06-24 |
AT372279B (de) | 1983-09-26 |
GB2038181B (en) | 1983-05-11 |
FR2444463A1 (fr) | 1980-07-18 |
NZ192457A (en) | 1983-06-17 |
CY1330A (en) | 1986-06-27 |
PT70614A (fr) | 1980-01-01 |
CH642259A5 (de) | 1984-04-13 |
DK529879A (da) | 1980-06-22 |
MY8500129A (en) | 1985-12-31 |
IT7951153A0 (it) | 1979-12-20 |
SE442265B (sv) | 1985-12-16 |
IL59003A (en) | 1982-12-31 |
SE7910227L (sv) | 1980-06-22 |
IT1164029B (it) | 1987-04-08 |
IE49323B1 (en) | 1985-09-18 |
NL187229C (nl) | 1991-07-16 |
KE3617D (en) | 1986-04-18 |
WO1980001242A1 (fr) | 1980-06-26 |
FR2444463B1 (fr) | 1983-02-25 |
DE2950154A1 (de) | 1980-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5407686A (en) | Sustained release composition for oral administration of active ingredient | |
KR100535954B1 (ko) | 장용 피복된 약학 정제 및 이의 제조방법 | |
US4816264A (en) | Sustained release formulations | |
US4252786A (en) | Controlled release tablet | |
US4666705A (en) | Controlled release formulation | |
US4756911A (en) | Controlled release formulation | |
KR100794427B1 (ko) | 직접 압축형 중합체 정제 코어 | |
WO2006070781A1 (fr) | Preparation a liberation controlee de type a matrice comprenant une substance basique ou un sel de celle-ci et procede pour la production de celle-ci | |
IE59089B1 (en) | Pharmaceutical composition | |
SK283081B6 (sk) | Tuhá perorálna aplikačná forma s regulovaným uvoľňovaním | |
CA2011919A1 (fr) | Materiel d'enrobage regulant la liberation d'une substance active pour les medicaments a action prolongee | |
TWI279232B (en) | Delayed-release preparations of quinolone antibiotics and processes for their preparation | |
SK104895A3 (en) | Pharmaceutical composition and its use | |
WO2006112596A1 (fr) | Preparation a liberation regulee contenant de l'hydrochlorure de tamsulosine | |
CA1139222A (fr) | Compose galenique | |
IE44540B1 (en) | Controlled release tablet | |
US5213806A (en) | Pharmaceutical composition comprising calcium polycarbophil | |
KR101246553B1 (ko) | 서방성 약제학적 조성물 및 이의 제조방법 | |
US20030099710A1 (en) | Granule modulating hydrogel system | |
WO1999044614A1 (fr) | Composition pharmaceutique contenant du cefuroxime axetil stable a l'absorption d'humidite | |
KR100315618B1 (ko) | 베타-페닐프로피오페논유도체의지연방출성미세정제 | |
US4411882A (en) | Galenical compositions | |
WO2004069234A1 (fr) | Compositions pharmaceutiques et procede de production | |
RU2359660C2 (ru) | Фармацевтическая композиция, содержащая производное пиримидин-а-она, покрытая кишечнорастворимым полимером | |
PL200822B1 (pl) | Kompozycja farmaceutyczna zawierająca rywastygminę |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |